UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3

Journal of Gynecologic Oncology, 2023, 34(2), , pp.1-26

2023

Volltextzugriff (PDF)

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience

Journal of Gynecologic Oncology, 2023, 34(6), , pp.1-15

2023

Volltextzugriff (PDF)

Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer

Journal of Gynecologic Oncology, 2024, 35(2), , pp.1-19

2024

Volltextzugriff (PDF)

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma

Journal of Gynecologic Oncology, 2017, 28(6), , pp.1-9

2017

Volltextzugriff (PDF)

Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer

Journal of Gynecologic Oncology, 2023, 34(2), , pp.1-12

2023

Volltextzugriff (PDF)

RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma

Journal of Gynecologic Oncology, 2023, 34(4), , pp.1-14

2023

Volltextzugriff (PDF)

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience

Journal of gynecologic oncology, 2023-11, Vol.34 (6), p.1

2023

Volltextzugriff (PDF)

RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma

Journal of gynecologic oncology, 2023-07, Vol.34 (4), p.1

2023

Volltextzugriff (PDF)

Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer

Journal of gynecologic oncology, 2024-03, Vol.35 (2), p.1

2024

Volltextzugriff (PDF)

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study

Journal of Gynecologic Oncology, 2019, 30(1), , pp.1-11

2019

Volltextzugriff (PDF)

Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer

Journal of gynecologic oncology, 2023-03, Vol.34 (2), p.1

2023

Volltextzugriff (PDF)

The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation

Journal of gynecologic oncology, 2024-04, Vol.35

2024

Volltextzugriff (PDF)

Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3

Journal of gynecologic oncology, 2023-03, Vol.34 (2), p.1

2023

Volltextzugriff (PDF)

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer

Journal of Gynecologic Oncology, 2020, 31(2), , pp.1-10

2020

Volltextzugriff (PDF)

Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center

Journal of Gynecologic Oncology, 2018, 29(4), , pp.1-10

2018

Volltextzugriff (PDF)

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

Journal of Gynecologic Oncology, 2019, 30(6), , pp.1-8

2019

Volltextzugriff (PDF)

Sentinel lymph node mapping with indocyanine green in vaginal cancer

Journal of Gynecologic Oncology, 2017, 28(4), , pp.1-2

2017

Volltextzugriff (PDF)

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer

Journal of gynecologic oncology, 2020-03, Vol.31 (2), p.1

2020

Volltextzugriff (PDF)

Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer

Journal of Gynecologic Oncology, 2015, 26(3), , pp.171-178

2015

Volltextzugriff (PDF)

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study

Journal of gynecologic oncology, 2019-01, Vol.30 (1), p.1

2019

Volltextzugriff (PDF)

Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center

Journal of gynecologic oncology, 2018-07, Vol.29 (4), p.1

2018

Volltextzugriff (PDF)

Sentinel lymph node mapping with indocyanine green in vaginal cancer

Journal of gynecologic oncology, 2017-07, Vol.28 (4), p.1

2017

Volltextzugriff (PDF)

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma

Journal of gynecologic oncology, 2017-11, Vol.28 (6), p.1

2017

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research And Treatment

SpracheNiederländisch

Zeitschrift / SerieJournal Of Gynecologic Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(15)
Koreanisch
(13)

Erscheinungsjahr

n.n

Thema

산부인과학
(14)
Life Sciences & Biomedicine
(13)
Obstetrics & Gynecology
(13)
Oncology
(13)
Science & Technology
(13)
Ovarian Neoplasms
(10)
Female
(9)
Humans
(9)
Original
(8)
Immunotherapy
(7)
Molecular Targeted Therapy
(6)
Neoadjuvant Chemotherapy
(6)
Neoadjuvant Therapy
(6)
Ovarian Cancer
(6)
Ovarian Neoplasms - Pathology
(6)
Neoplasm Staging
(5)
Ovarian Neoplasms - Drug Therapy
(5)
Adult
(4)
Chemotherapy
(4)
Hyperthermic Intraperitoneal Chemotherapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Free E-Journal (出版社公開部分のみ）
(28)
MEDLINE
(9)

Menü

Weitere Dienste

Einstellungen

Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience

Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma

Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer

RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience

Asian Society of Gynecologic Oncology International Workshop 2018

RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma

Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study

Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer

The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation

Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer

Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

Sentinel lymph node mapping with indocyanine green in vaginal cancer

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer

Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study

Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center

Sentinel lymph node mapping with indocyanine green in vaginal cancer

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma

Asian Society of Gynecologic Oncology International Workshop 2018

Aktive Filter

Suchergebnisse filtern